Usefulness of polymorphic markers in exclusion of BRCA1/BRCA2 mutations in families with aggregation of breast/ovarian cancers

Journal of Applied Genetics

Volumn 44, Issue 3, 2003, Pages 419-423

  Górski, Bohdan ^a   Dȩbniak, Tadeusz ^a   Jakubowska, Anna ^a   Cybulski, Cezary ^a   Huzarski, Tomasz ^a   Byrski, Tomasz ^a   Złowocka, Elzbieta ^a   Lubiński, Jan ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

BRCA1; BRCA2; Breast; Cancer; Inherited predisposition; Ovarian

Indexed keywords

BRCA2 PROTEIN;

ALLELE; ARTICLE; BLOOD SAMPLING; BREAST CARCINOMA; EXON; FUNCTIONAL ASSESSMENT; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC CODE; GENETIC MARKER; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; MICROSATELLITE MARKER; ONCOGENE; OVARY CARCINOMA; POLAND;

BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC;

EID: 0141464966     PISSN: 12341983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. CLAUS E.B., RISCH N., THOMPSON W.D. (1991). Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am. J. Hum. Genet. 48: 232-242.
2. COUCH F.J., FARID L.M., DESHANO M.L., TAVTIGIAN S.V., CALZONE K., CAMPEAU L., PENG Y. et al. (1996). BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet. 13: 123-125.
3. EASTON D.F., BISHOP D.T., FORD D., CROCKFORD G.P. (1993). Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am. J. Hum. Genet. 52: 678-701.
4. FORD D., EASTON D.F., BISHOP D.T., NAROD S.A., GOLDGAR D.E. (1994). Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet. 343: 692-695.
5. GÓRSKI B., BYRSKI T., HUZARSKI T., JAKUBOWSKA A., MENKISZAK J., GRONWALD J., PLUZANSKA A., BEBENEK M., FISCHER-MALISZEWSKA L., GRZYBOWSKA E., NAROD S.A., LUBIŃSKI J. (2000). Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer. Am. J. Hum. Genet. 66(6): 1963-1968.
6. HALL J.M., LEE M.K., NEWMAN B., MORROW J., ANDERSON A., HUEY B., KING M-C. (1990). Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science. 250: 1684-1689.
7. 2, EDTA, storage time, and temperature on DNA yield and quality. Biochem. Genet. 31: 321-328.
8. MIKI Y., SWENSEN J., SHATTUCK-EIDENS D., FUTREAL P.A., HARSHMAN K., TAVTIGIAN S., LIU Q.Y. et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266: 66-71.
9. NAROD S.A., FEUNTEUN M., LYNCH H.T., WATSON P., CONOWAY T., LYNCH J., LENOIR G.M. (1991). Familial breast-ovarian cancer locus on chromosome 17q12-23. Lancet. 338: 82-83.
10. NEWMAN B., AUSTIN M.A., LEE M., KING M-C. (1988). Inheritance of human breast cancer: evidence for autosomal dominant transmission in high risk families. Proc. Natl. Acad. Sci. USA. 85: 3044-3048.
11. SCULLY R., GANESAN K., VLASAKOVA K., CHEN J., SOCOLOVSKY M., LIVINGSTON D.M. (1999). Genetic analysis of BRCA1 function in a defined tumour cell line. Mol. Cell. 4: 1093-1099.
12. STRUEWING J.P., ABELIOVICH D., PERETZ T., AVISHAI N., KABACK M.M., COLLINS F.S., BRODY L.C. (1995). The carrier of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat. Genet. 11: 198-200.
13. SZABO C., KING M.C. (1997). Population genetics of BRCA1 and BRCA2. Am. J. Hum. Genet. 60: 1013-1020.
14. TONIN P., SEROVA O., LENOIR G., LYNCH H., DUROCHER F., SIMARD J., MORGAN K. et al. (1995). BRCA1 mutations in Ashkenazi Jewish women. Am. J. Hum. Genet. 57: 189.
15. WOOSTER R., BIGNELL G., LANCASTER J., SWIFT S., SEAL S., MANGION J., COLLINS N. et al. (1995). Identification of the breast cancer gene BRCA2. Nature. 378: 789-792.